SpringWorks Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
190.85 |
335.06 |
612.33 |
839.18 |
893.60 |
1,042.90 |
| Przychód Δ r/r |
0.00% |
75.56% |
82.75% |
37.05% |
6.48% |
16.71% |
| Przychód (min) |
169.36 |
297.60 |
480.47 |
712.99 |
759.23 |
886.08 |
| Przychód (max) |
201.12 |
402.89 |
758.20 |
986.67 |
1,050.65 |
1,226.19 |
| EBITDA (średnia) |
-114.51 |
-201.04 |
-367.40 |
-503.51 |
-536.16 |
-625.74 |
| EBIT (średnia) |
-114.51 |
-201.04 |
-367.40 |
-503.51 |
-536.16 |
-625.74 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-223.12 |
-203.83 |
-86.16 |
76.30 |
289.12 |
116.39 |
| Zysk netto % |
-116.91% |
-60.83% |
-14.07% |
9.09% |
32.35% |
11.16% |
| EPS (średnia) |
-3.05 |
-2.75 |
-0.83 |
1.72 |
3.90 |
1.57 |
| Liczba analityków (Przychody) |
6 |
5 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
6 |
4 |
3 |
2 |
1 |
1 |
| symbol |
SWTX |
SWTX |
SWTX |
SWTX |
SWTX |
SWTX |